Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
News
Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025
REGULATED INFORMATION May 9, 2025, 7:00am CET / 1:00am ET NYXOAH SA (Euronext Brussels: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the “Company”) Invitation to attend the annual and the extraordinary shareholders' meetings of the Company to be held on June 11, 2025 The board of directors of the Company is pleased to invite its securities holders to attend the annual shareholders' meeting of the Company, to be held on Wednesday, June 11, 2025 at 2:00 p.m. CET at the Company's seat, or at such other place as will be indicated prior to such time.» Mehr auf globenewswire.com
argenx Reports First Quarter 2025 Financial Results and Provides Business Update
$790 million in first quarter global product net sales First patients treated with VYVGART Hytrulo pre-filled syringe for self-injection in US and Germany CIDP global expansion with positive CHMP opinion for VYVGART-SC (vial and pre-filled syringe) in EU Management to host conference call today at 2:30 PM CET (8:30 AM ET) May 8, 2025, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its first quarter 2025 financial results and provided a business update. “We continue to execute on our bold innovation agenda, guided by our ‘Vision 2030' to reach 50,000 patients across 10 labeled indications,” said Tim Van Hauwermeiren, Chief Executive Officer of argenx.» Mehr auf globenewswire.com
International Petroleum Corporation to release Q1 2025 Financial and Operational Results on May 6, 2025
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- International Petroleum Corporation (IPC) (TSX, Nasdaq Stockholm: IPCO) will publish its financial and operating results and related management's discussion and analysis for the three months ending 31 March 2025, on Tuesday, May 6, 2025 at 07:30 CET, followed by an audiocast at 09:00 CET.» Mehr auf globenewswire.com
Historische Dividenden
Alle Dividenden KennzahlenUnternehmenszahlen
(EUR) | Dez. 2024 | |
---|---|---|
Umsatz | 30,04 Mio | - |
Bruttoeinkommen | 27,15 Mio | - |
Nettoeinkommen | 105,30 Mio | - |
EBITDA | 105,41 Mio | - |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 1,16 Mrd€ |
Anzahl Aktien | 28,93 Mio |
52 Wochen-Hoch/Tief | 43,99€ - 35,76€ |
Dividendenrendite | 5,43% |
Dividenden TTM | 2,15€ |
Beta | 0,73 |
KGV (PE Ratio) | 4,55 |
KGWV (PEG Ratio) | −1,95 |
KBV (PB Ratio) | 0,83 |
KUV (PS Ratio) | 17,76 |
Unternehmensprofil
Central Securities Corp. ist ein staatlicher Vermögensverwalter. Das Unternehmen investiert in die öffentlichen Aktienmärkte der Vereinigten Staaten. Sie investiert auch in Anleihen, Wandelanleihen, Vorzugsaktien, wandelbare Vorzugsaktien, Optionsscheine, Immobilienoptionen oder kurzfristige Verpflichtungen von Regierungen, Banken und Unternehmen. Die Central Securities Corp. wurde am 1. Oktober 1929 gegründet und hat ihren Sitz in New York, New York.
Name | CENTRAL SEC. DL 1 |
CEO | John C. Hill |
Sitz | New York, ny USA |
Website | |
Börsengang | |
Mitarbeiter | 6 |
Ticker Symbole
Börse | Symbol |
---|---|
NYSE | CET |
Assets entdecken
Shareholder von CENTRAL SEC. DL 1 investieren auch in folgende Assets